NGS Technology in Monitoring the Genetic Diversity of Cytomegalovirus Strains

Modern molecular genetic methods, massive parallel sequencing in particular, allow for genotyping of various pathogens with the aim of their epidemiological marking and improvement of molecular epidemiological surveillance of actual infections, including cytomegalovirus infection.

The aim of the study is to evaluate the next-generation sequencing (NGS) technology for genotyping clinical isolates of cytomegalovirus (CMV).

Materials and Methods. The object of the study were samples of biological substrates (leukocyte mass, saliva, urine) taken from patients who underwent liver and kidney transplantation. Detection of CMV DNA was carried out by a real-time PCR using commercial diagnostic AmpliSense CMV-FL test systems (Central Research Institute for Epidemiology, Moscow, Russia). DNA extraction was performed using DNA-sorb AM and DNA-sorb V kits (Central Research Institute for Epidemiology) in accordance with manufacturer’s manual. The quality of the prepared DNA library for sequencing was assessed by means of the QIAxcel Advanced System capillary gel electrophoresis system (QIAGEN, Germany). Alignment and assembly of nucleotide sequences were carried out using CLC Genomics Workbench 5.5 software (CLC bio, USA). The sequencing results were analyzed using BLAST of NCBI server.

Results. CMV DNA samples were selected for genotyping. The two variable genes, UL55(gB) and UL73(gN), were used for CMV genotype determination, which was performed using NGS technology MiSeq sequencer (Illumina, USA). Based on the exploratory studies and analysis of literature sources, primers for genotyping on the UL55(gB) and UL73(gN) genes have been selected and the optimal conditions for the PCR reaction have been defined. The results of sequencing the UL55(gB) and UL73(gN) gene fragments of CMV clinical isolates from recipients of solid organs made it possible to determine the virus genotypes, among which gB2, gN4c, and gN4b were dominant. In some cases, association of two and three CMV genotypes has been revealed.

Conclusion. The application of the NGS technology for genotyping cytomegalovirus strains can become one of the main methods of CMV infection molecular epidemiology, as it allows for obtaining reliable results with a significant reduction in research time.

1. Zhebrun A.B., Kulyashova L.B., Ermolenko K.D., Zakrevskaya A.V. Spread of herpesvirus infections in children and adults in St. Petersburg according to seroepidemiologic study data. Zhurnal mikrobiologii, epidemiologii i immunobiologii 2013; 6: 30–36.
2. Dmitrachenko T.I., Harbachou V.V., Semenov V.M., Ziankova S.K., Shpigun N.V. Reactivation of cytomegalovirus infection in patients being in critical state. Vestnik Vitebskogo gosudarstvennogo medicinskogo universiteta 2018; 17(3): 25–37.
3. Pignatelli S., Dal Monte Р., Rossini G., Landini M.P. Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev Med Virol 2004; 14(6): 383–410, https://doi.org/10.1002/rmv.438.
4. Chou S.W., Dennison K.M. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization related epitopes. J Infect Dis 1991; 163(6): 1229–1234, https://doi.org/10.1093/infdis/163.6.1229.
5. Suárez N.M., Wilkie G.S., Hage E., Camiolo S., Holton M., Hughes J., Maabar M., Vattipally S.B., Dhingra A., Gompels U.A., Wilkinson G.W.G., Baldanti F., Furione M., Lilleri D., Arossa A., Ganzenmueller T., Gerna G., Hubáček P., Schulz T.F., Wolf D., Zavattoni M., Davison A.J. Human cytomegalovirus genomes sequenced directly from clinical material: variation, multiple-strain infection, recombination, and gene loss. J Infect Dis 2019; 220(5): 781–791, https://doi.org/10.1093/infdis/jiz208.
6. Yan H., Koyano S., Inami Y., Yamamoto Y., Suzutani T., Mizuguchi M., Ushijima H., Kurane I., Inoue N. Genetic variations in the gB, UL144 and UL149 genes of human cytomegalovirus strains collected from congenitally and postnatally infected Japanese children. Arch Virol 2008; 153(4): 667–674, https://doi.org/10.1007/s00705-008-0044-7.
7. Dolan A., Cunningham C., Hector R.D., Hassan-Walker A.F., Lee L., Addison C., Dargan D.J., McGeoch D.J., Gatherer D., Emery V.C., Griffiths P.D., Sinzger C., McSharry B.P., Wilkinson G.W.G., Davison A.J. Genetic content of wild-type human cytomegalovirus. J Gen Virol 2004; 85(Pt 5): 1301–1312, https://doi.org/10.1099/vir.0.79888-0.
8. Brait N., Külekçi B., Goerzer I. Long range PCR-based deep sequencing for haplotype determination in mixed HCMV infections. BMS Genomics 2022; 23(1): 31, https://doi.org/10.1186/s12864-021-08272-z.
9. Dhingra A., Götting J., Varanasi P.R., Steinbrueck L., Camiolo S., Zischke J., Heim A., Schulz T.F., Weissinger E.M., Kay-Fedorov P.C., Davison A.J., Suárez N.M., Ganzenmueller T. Human cytomegalovirus multiple-strain infections and viral population diversity in haematopoietic stem cell transplant recipients analysed by high-throughput sequencing. Med Microbiol Immunol 2021; 210(5–6): 291–304, https://doi.org/10.1007/s00430-021-00722-5.
10. Martí-Carreras J., Maes P. Human cytomegalovirus genomics and transcriptomics through the lens of next-generation sequencing: revision and future challenges. Virus Genes 2019; 55(2): 138–164, https://doi.org/10.1007/s11262-018-1627-3.
11. Pignatelli S., Dal Monte P., Rossini G., Chou S., Gojobori T., Hanada K., Guo J.J., Rawlinson W., Britt W., Mach M., Landini M.P. Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants: identification of a novel subgroup, geographical distribution and evidence of positive selective pressure. J Gen Virol 2003; 84(Pt 3): 647–655, https://doi.org/10.1099/vir.0.18704-0.
12. Dorado G., Gálvez S., Rosales T.E., Vásquez V.F., Hernández P. Analyzing modern biomolecules: the revolution of nucleic-acid sequencing — review. Biomolecules 2021; 11(8): 1111, https://doi.org/10.3390/biom11081111.
13. Renzette N., Pokalyuk C., Gibson L., Bhattacharjee B., Schleiss M.R., Hamprecht K., Yamamoto A.Y., Mussi-Pinhata M.M., Britt W.J., Jensen J.D., Kowalik T.F. Limits and patterns of cytomegalovirus genomic diversity in humans. Proc Natl Acad Sci U S A 2015; 112(30): E4120–E4128, https://doi.org/10.1073/pnas.1501880112.
14. Wu X.J., Wang Y., Zhu Z.L., Xu Y., He G.S., Han Y., Tang X.W., Fu Z.Z., Qiu H.Y., Sun A.N., Wu D.P. The correlation of cytomegalovirus gB genotype with viral DNA load and treatment time in patients with CMV infection after hematopoietic stem cell transplantation. Zhonghua Xue Ye Xue Za Zhi 2013; 34(2): 109–112.
15. de Albuquerque D.M., Costa S.C. Genotyping of human cytomegalovirus using non-radioactive single-strand conformation polymorphism (SSCP) analysis. J Virol Methods 2003; 110(1): 25–28, https://doi.org/10.1016/s0166-0934(03)00094-6.
16. Barbi M., Binda S., Caroppo S., Calvario А., Germinario С., Bozzi А., Tanzi M.L., Veronesi L., Mura I., Piana А., Solinas G., Pugni L., Bevílaqua G., Mosca F. Multicity Italian study of congenital cytomegalovirus infection. Pediatr Infect Dis 2006; 25(2): 156–159, https://doi.org/10.1097/01.inf.0000199261.98769.29.
17. Shepp D.H., Match М.Е., Lipson S.M., Pergolizzi R.G. A fifth human cytomegalovirus glycoprotein B genotype. Res Virol 1998; 149(2): 109–111, https://doi.org/10.1016/s0923-2516(98)80086-1.
18. Grosjean J., Hantz S., Cotin S., Baclet M.C., Mengelle C., Trapes L., Virey B., Undreiner F., Brosset P., Pasquier C., Denis F., Alain S. Direct genotyping of cytomegalovirus envelope glycoproteins from toddler’s saliva samples. J Clin Virol 2009; 46 Suppl 4: S43–S48, https://doi.org/10.1016/j.jcv.2009.08.018.
19. de Vries J.J., Wessels E., Korver A.M., van der Eijk A.A., Rusman L.G., Kroes A.C., Vossen A.C. Rapid genotyping of cytomegalovirus in dried blood spots by multiplex real-time PCR assays targeting the envelope glycoprotein gB and gH genes. J Clin Microbiol 2012; 50(2): 232–237, https://doi.org/10.1128/jcm.05253-11.
20. Lisboa L.F., Tong Y., Kumar D., Pang X.L., Asberg A., Hartmann A., Rollag H., Jardine A.G., Pescovitz M.D., Humar A. Analysis and clinical correlation of genetic variation in cytomegalovirus. Transpl Infect Dis 2012; 14(2): 132–140, https://doi.org/10.1111/j.1399-3062.2011.00685.x.
21. Jiang X.J., Zhang J., Xiong Y., Jahn G., Xiong H.R., Yang Z.Q., Liu Y.Y. Human cytomegalovirus glycoprotein polymorphisms and increasing viral load in AIDS patients. PLoS One 2017; 12(5): e0176160, https://doi.org/10.1371/journal.pone.0176160.
22. Pignatelli S. Recent knowledges on the linkage of strain specific genotypes with clinical manifestations of human citomegalovirus disease. Recenti Prog Med 2011; 102(1): 5–10.
23. Garcia de Figueiredo G., Marques A.A., Mussi-Pinhata M.M., Silva W.A. Jr., Yamamoto A.Y. Is the mixture of human cytomegalovirus genotypes frequent in infants with congenital infection at birth in a high seroprevalence population? J Med Virol 2018; 90(8): 1389–1397, https://doi.org/10.1002/jmv.25205.
24. Külekci В., Schwarz S., Brait N., Perkmann-Nagele N., Jaksch P., Hoetzenecker K., Puchhammer-Stöckl E., Goerzer I. Human cytomegalovirus strain diversity and dynamics reveal the donor lung as a major contributor after transplantation. Virus Evol 2022; 8(2): veac076, https://doi.org/10.1093/ve/veac076.

Vankova O.E., Brusnigina N.F., Novikova N.A. NGS Technology in Monitoring the Genetic Diversity of Cytomegalovirus Strains. Sovremennye tehnologii v medicine 2023; 15(2): 41, https://doi.org/10.17691/stm2023.15.2.04